SUBACUTE TOXICITY AND RECOVERY TESTS OF INTRAVENOUS DEHYDROEPIANDROSTERONE SULFATE (DHA-S) IN BEAGLE DOGS
スポンサーリンク
概要
- 論文の詳細を見る
At dose levels of 5, 20 and 60 mg/kg, dehydroepiandrosterone sulfate (DHA-S) was given intravenously for 30 successive days to female beagle dogs with the following results. 1) The chief general symptoms were vomiting, salivation and discharge of milk. Vomiting and salivation developed after the drug in doses of more than 20 mg/kg and in the dose of 60 mg/kg respectively, while discharge of milk was seen in dogs treated with the drug of more than 20mg/kg. 2) Hematological, serum biochemical and urinary examinations revealed no abnormalities. 3) Examination of organ weights disclosed only an increasing tendency of the liver weight in 60mg/kg group. 4) Histological findings were slight degranulation of the pituitary basophil in 60mg/kg group and atrophic tendency of the thymus in 1 out of the 3 dogs of the same group. Narrowing of the adrenal zona fasciculata occurred in 1 out of the 3 dogs of 60mg/kg group. Luteinization in the ovary was especially remarkable in 60mg/kg group. Secretion from the uterine glandular cell and edematous tendency of the endometrium were detected mostly in 60mg/kg group. Dogs of 20 and 60mg/kg groups showed proliferation of mammary gland cells with discharge of milk. 5) There were no abnormalities on electron micrography of the liver. 6) All changes mentioned above essentially disappeared during the recovery test of 1 month's duration. Therefore, a possible maximum dose of DHA-S which does notcause adverse reaction was evidenced to be about 20 mg/kg in dogs.
- 日本トキシコロジー学会の論文
- 1977-04-15
著者
-
UNNO Takashi
Pharmaceutical Research and Manufactures of America
-
Iino Tetsuo
Pharmaceuticals Research Center Kanebo Ltd.
-
Unno Takashi
Pharmaceuticals Research Center Kanebo Ltd.
-
YAHARA Miyakichi
Pharmaceuticals Research Center, Kanebo, Ltd.
-
INOUYE Toshio
Pharmaceuticals Research Center, Kanebo, Ltd.
-
OGINO Fumio
Pharmaceuticals Research Center, Kanebo, Ltd.
-
TERAMOTO Mariko
Pharmaceuticals Research Center, Kanebo, Ltd.
-
NOSE Takashi
Pharmaceuticals Research Center, Kanebo, Ltd.
-
MIDORIKAWA Osamu
Department of Pathology, Faculty of Medicine, Kyoto University
-
Ogino Fumio
Pharmaceuticals Research Center Kanebo Ltd.
-
Nose Takashi
Pharmaceuticals Research Center Kanebo Ltd.
-
Inouye Toshio
Pharmaceuticals Research Center Kanebo Ltd.
-
Teramoto Mariko
Pharmaceuticals Research Center Kanebo Ltd.
-
Midorikawa Osamu
Department Of Pathology Faculty Of Medicine Kyoto University
-
Yahara Miyakichi
Pharmaceuticals Research Center Kanebo Ltd.
関連論文
- CURRENT OPINION : SAFETY EVALUATION OF DRUG METABOLITES IN DEVELOPMENT OF PHARMACEUTICALS
- SUBACUTE TOXICITY AND RECOVERY TESTS OF INTRAVENOUS DEHYDROEPIANDROSTERONE SULFATE (DHA-S) IN BEAGLE DOGS
- EFFECT OF CIANIDANOL (KB-53) ON THE ACTIVITY OF MOUSE NATURAL KILLER CELLS
- EFFECT OF CIANIDANOL (KB-53) ON THE ACTIVITY OF MOUSE CYTOTOXIC-T-LYMPHOCYTES
- INCREASED LYSYL OXIDASE ACTIVITY IN BLOOD VESSELS OF HYPERTENSIVE RATS AND EFFECT OF β-AMINOPROPIONITRILE ON ARTERIOSCLEROSIS
- Functional Aspects of the Pancreatic Islets Based On Histochemistry
- ENZYME-IMMUNOHISTOCHEMICAL STUDIES OF ARGYROPHIL CELLS IN NORMAL ISLETS AND ISLET CELL TUMORS (HISTOCHEMISTRY AND CYTOCHEMISTRY OF ENDOCRINE ORGANS)